Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ICCC

ImmuCell (ICCC)

ImmuCell Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ICCC
DateTimeSourceHeadlineSymbolCompany
06/06/20246:49AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
06/05/20243:05PMGlobeNewswire Inc.ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®NASDAQ:ICCCImmuCell Corporation
06/04/20243:05PMGlobeNewswire Inc.ImmuCell to Hold Virtual-Only Annual Meeting of StockholdersNASDAQ:ICCCImmuCell Corporation
05/22/20243:50PMEdgar (US Regulatory)Form SCHEDULE 13D - General statement of acquisition of beneficial ownershipNASDAQ:ICCCImmuCell Corporation
05/14/20243:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ICCCImmuCell Corporation
05/14/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
05/14/20243:05PMGlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024NASDAQ:ICCCImmuCell Corporation
05/08/202412:00PMGlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024NASDAQ:ICCCImmuCell Corporation
04/09/20243:05PMGlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024NASDAQ:ICCCImmuCell Corporation
03/06/202412:55PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
02/27/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
02/27/20243:05PMGlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023NASDAQ:ICCCImmuCell Corporation
02/16/20248:30AMGlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023NASDAQ:ICCCImmuCell Corporation
01/08/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
01/08/20243:05PMGlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023NASDAQ:ICCCImmuCell Corporation
11/16/20232:22PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
11/13/20233:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ICCCImmuCell Corporation
11/13/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
11/13/20233:05PMGlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023NASDAQ:ICCCImmuCell Corporation
11/07/202311:15AMGlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023NASDAQ:ICCCImmuCell Corporation
10/05/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
10/05/20233:05PMGlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023NASDAQ:ICCCImmuCell Corporation
09/06/202311:25AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICCCImmuCell Corporation
08/30/20231:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICCCImmuCell Corporation
08/29/20237:00AMGlobeNewswire Inc.ImmuCell Announces Submission of CMC Technical Section to the FDANASDAQ:ICCCImmuCell Corporation
08/10/20233:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ICCCImmuCell Corporation
08/10/20233:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ICCCImmuCell Corporation
08/10/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
08/10/20233:05PMGlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023NASDAQ:ICCCImmuCell Corporation
08/07/202311:00AMGlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023NASDAQ:ICCCImmuCell Corporation
 Showing the most relevant articles for your search:NASDAQ:ICCC